Trends over time in the risk of adverse outcomes among patients with SARS-CoV-2 infection.

George N IoannouAnn M O'HareKristin BerryVincent S FanKristina CrothersMcKenna C EastmentEmily LockePamela GreenJaveed A ShahJason A Dominitz

Published in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)

The risk of adverse outcomes in SARS-CoV-2-positive patients decreased markedly between February and July, with subsequent stabilization from July to September. These trends were not explained by changes in measured baseline patient characteristics and may reflect changing treatment practices or viral pathogenicity.

Keyphrases

sars cov
end stage renal disease
respiratory syndrome coronavirus
ejection fraction
primary care
newly diagnosed
healthcare
chronic kidney disease
case report
cystic fibrosis
biofilm formation
staphylococcus aureus
smoking cessation